Shares of Philip Morris extended their recent bounce Thursday after the U.S. Food and Drug Administration authorized the ...
The increasingly popular nicotine pouches pose a lower risk of cancer than cigarettes, U.S. health officials said.
In a statement, the FDA said it has authorized the marketing and sale of Philip Morris International’s Zyn nicotine pouches.
Shares of British American Tobacco (BATS:LN) (NYSE: NYSE:BTI), Altria Group (NYSE: NYSE:MO), and Philip Morris International ...
Federal health officials are backing the health benefits of nicotine pouches, ruling that Philip Morris International’s Zyn ...
The Food and Drug Administration has authorized ZYN nicotine pouches, “making ZYN the first and only authorized nicotine pouch in the United ...
The Food and Drug Administration OK'd 10 Zyn flavors, including coffee, mint and menthol. It's the first time regulators have ...
Philip Morris International shares edged up slightly after the Food and Drug Administration authorized marketing for 20 Zyn nicotine-pouch products. The stock rose about 1%, to $119.40, late Thursday ...
The U.S. Food and Drug Administration has authorized all ZYN Nicotine Pouch Products Currently Marketed by Swedish Match, a ...
These items have become popular in c-stores as traditional tobacco sales plunge, and their approval sets the stage for ...
The authorization means pouches can be marketed to adults 21 or older but doesn’t mean the products are “FDA approved.” ...